These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 35085623)

  • 1. Monocytes as a convergent nanoparticle therapeutic target for cardiovascular diseases.
    Aldarondo D; Wayne E
    Adv Drug Deliv Rev; 2022 Mar; 182():114116. PubMed ID: 35085623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease.
    Lameijer MA; Tang J; Nahrendorf M; Beelen RH; Mulder WJ
    Expert Rev Mol Diagn; 2013 Jul; 13(6):567-80. PubMed ID: 23895127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
    Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
    Front Immunol; 2019; 10():1378. PubMed ID: 31275317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein mimetic nano-therapeutics targeting monocytes and macrophages for improved cardiovascular care: a comprehensive review.
    Zhen J; Li X; Yu H; Du B
    J Nanobiotechnology; 2024 May; 22(1):263. PubMed ID: 38760755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular disease in diabetes.
    Bloomgarden ZT
    Diabetes Care; 2010 Apr; 33(4):e49-54. PubMed ID: 20351221
    [No Abstract]   [Full Text] [Related]  

  • 6. Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases.
    Aizik G; Grad E; Golomb G
    Drug Deliv Transl Res; 2018 Aug; 8(4):868-882. PubMed ID: 29058205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease.
    Flierl U; Bauersachs J; Schäfer A
    Eur J Clin Invest; 2015 Jun; 45(6):624-33. PubMed ID: 25832902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brief comments on the issue of cardiovascular risk in diabetic patients.
    Lasaridis AN
    Am J Hypertens; 2004 Jul; 17(7):640. PubMed ID: 15233987
    [No Abstract]   [Full Text] [Related]  

  • 9. HAART and cardiology--current controversies and consequences.
    Hoffmann C; Jaeger H
    Adv Cardiol; 2003; 40():1-14. PubMed ID: 14533543
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy.
    Zungsontiporn N; Tello RR; Zhang G; Mitchell BI; Budoff M; Kallianpur KJ; Nakamoto BK; Keating SM; Norris PJ; Ndhlovu LC; Souza SA; Shikuma CM; Chow DC
    PLoS One; 2016; 11(2):e0149143. PubMed ID: 26867220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathophysiology of cardiovascular disease in diabetes mellitus and the future of therapy.
    Thomas JE; Foody JM
    J Cardiometab Syndr; 2007; 2(2):108-13. PubMed ID: 17684463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Mechanisms in Monocytes/Macrophages Regulate Inflammation in Cardiometabolic and Vascular Disease.
    Davis FM; Gallagher KA
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):623-634. PubMed ID: 30760015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between co-morbidity and the use of antidiabetics or adjunctive cardiovascular medicines in Australian veterans with diabetes.
    Zhang Y; Vitry A; Caughey G; Roughead EE; Ryan P; Gilbert A; Shakib S; McDermott R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):115-20. PubMed ID: 21067836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disordered haematopoiesis and cardiovascular disease: a focus on myelopoiesis.
    Dragoljevic D; Westerterp M; Veiga CB; Nagareddy P; Murphy AJ
    Clin Sci (Lond); 2018 Sep; 132(17):1889-1899. PubMed ID: 30185612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocyte/macrophages and their role in HIV neuropathogenesis.
    Burdo TH; Lackner A; Williams KC
    Immunol Rev; 2013 Jul; 254(1):102-13. PubMed ID: 23772617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.
    Dray-Spira R; Legeai C; Le Den M; Boué F; Lascoux-Combe C; Simon A; May T; Goujard C; Meyer L;
    AIDS; 2012 Jan; 26(2):207-15. PubMed ID: 22008658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte chemokine receptors as therapeutic targets in cardiovascular diseases.
    Germano DB; Oliveira SB; Bachi ALL; Juliano Y; Novo NF; Bussador do Amaral J; França CN
    Immunol Lett; 2023; 256-257():1-8. PubMed ID: 36893859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte function and trafficking in cardiovascular disease.
    Pardali E; Waltenberger J
    Thromb Haemost; 2012 Nov; 108(5):804-11. PubMed ID: 22918193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory co-morbidities in people with HIV.
    Brown J; Smith C; Johnson M; Lipman M; Abubakar I
    Lancet Infect Dis; 2016 Jan; 16(1):21. PubMed ID: 26738830
    [No Abstract]   [Full Text] [Related]  

  • 20. Respiratory co-morbidities in people with HIV.
    Smit M; Hallett T
    Lancet Infect Dis; 2016 Feb; 16(2):152. PubMed ID: 26867459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.